Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion

Cancer Research

Volumn 69, Issue 15, 2009, Pages 6355-6363

  Teoh, Melissa L T ^a   Fitzgerald, Matthew P ^a   Oberley, Larry W ^a   Domann, Frederick E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACELLULAR SUPEROXIDE DISMUTASE; HEPARANASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NEOPLASM INVASIVENESS; RNA, MESSENGER; RNA, SMALL INTERFERING; SUPEROXIDE DISMUTASE; SUPEROXIDES; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68049143319     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1195     Document Type: Article

References (46)

1. Cohen I, Pappo O, Elkin M, et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 2006;118:1609-1617 (Pubitemid 43376422)
2. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 2006;66:10233-10237 (Pubitemid 44799736)
3. Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological functions, and inhibition by heparinderived mimetics of heparan sulfate. Curr Pharm Des 2007;13:2057-2073 (Pubitemid 47044735)
4. Iozzo RV. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 2001; 108:165-167
5. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-777 (Pubitemid 29449208)
6. Vlodavsky I, Abboud-Jarrous G, Elkin M, et al. The impact of heparanese and heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb 2006; 35:116-127 (Pubitemid 44350173)
7. Boyd DD, Nakajima M. Involvement of heparanase in tumor metastases: a new target in cancer therapy? J Natl Cancer Inst 2004;96:1194-1195
8. Vlodavsky I, Elkin M, Abboud-Jarrous G, et al. Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res 2008;49:207-210
9. McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007; 151:1-14. (Pubitemid 46675998)
10. Norrby K. Low-molecular-weight heparins and angiogenesis. APMIS 2006;114:79-102.
11. Raats CJ, Bakker MA, van den Born J, Berden JH. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 1997;272:26734-26741
12. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002;33:337-349
13. Sandstrom J, Carlsson L, Marklund SL, Edlund T. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem 1992;267:18205-18209
14. Lookene A, Stenlund P, Tibell LA. Characterization of heparin binding of human extracellular superoxide dismutase. Biochemistry 2000;39:230-236
15. Enghild JJ, Thogersen IB, Oury TD, Valnickova Z, Hojrup P, Crapo JD. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J Biol Chem 1999;274:14818-14822 (Pubitemid 129518811)
16. Sandstrom J, Karlsson K, Edlund T, Marklund SL. Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J 1993;294:853-857 (Pubitemid 23286577)
17. Karlsson K, Marklund SL. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J 1987;242:55-59 (Pubitemid 17015446)
18. Adachi T, Hara H, Yamada H, et al. Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts. Atherosclerosis 2001;159:307-312 (Pubitemid 33127244)
19. Weydert CJ, Zhang Y, Sun W, et al. Increased oxidative stress creased by MnSOD or CuZnSOD plus BCNU inhibited breast cancer cell growth. Free Radic Biol Med 2008;44:856-867
20. TeohML T, Sun W, Smith B, Oberley LW, Cullen JJ. Modulation of ROS in pancreatic cancer: insight into tumor suppression by superoxide dismutases. Clin Cancer Res 2007;13:7441-7450
21. Chu Y, Iida S, Lund DD, et al. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 2003;92:461-468 (Pubitemid 36298207)
22. Nakane H, Chu Y, Faraci FM, Oberley LW, Heistad DD. Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid. Stroke 2001;32:184-189 (Pubitemid 32063844)
23. Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 2005; 112:1047-1053 (Pubitemid 41170274)
24. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-287
25. Lam EW, Zwacka R, Engelhardt JF, et al. Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells. Cancer Res 1997;57:5550-5556 (Pubitemid 28006763)
26. BreidenbachM, Rein DT, Schondorf T, et al. A new targeting approachfor breast cancer gene therapy using the heparanase promoter. Cancer Lett 2006;240: 114-122 (Pubitemid 44055993)
27. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992;119:961-975
28. Solic N, Wilson J, Wilson SJ, Shute JK. Endothelial activation and increased heparan sulfate expression in cystic fibrosis. Am J Respir Crit Care Med 2005;172: 892-898 (Pubitemid 41369074)
29. Mellor P, Harvey JR, Murphy KJ, et al. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDAMB 231 breast cancer cells in vivo . Br J Cancer 2007; 97:761-768 (Pubitemid 47396282)
30. Wheeler MD, Smutney OM, Samulski RJ. Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growthof B16 melanomas in mice. Mol Cancer Res 2003;1:871-881
31. Brown KA, Chu Y, Lund DD, Heistad DD, Faraci FM. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction withaging. Am J Physiol Heart Circ Physiol 2006;290:H2600-5. (Pubitemid 43846091)
32. Chu Y, Piper R, Richardson S, Watanabe Y, Patel P, Heistad DD. Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparinbinding domain. Arterioscler Thromb Vasc Biol 2006;26: 1985-1990 (Pubitemid 44253778)
33. Ohta H, Adachi T, Hirano K. Internalization of human extracellular- superoxide dismutase by bovine aortic endothelial cells. Free Radic Biol Med 1994;16: 501-507 (Pubitemid 24105998)
34. Adachi T, Kodera T, Ohta H, Hayashi K, Hirano K. The heparin binding site of human extracellular-superoxide dismutase. Arch Biochem Biophys 1992;297: 155-161
35. Karlsson K, Lindahl U, Marklund SL. Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J 1988;256:29-33. (Pubitemid 18273438)
36. Gao F, Koenitzer JR, Tobolewski JM, et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 2008;283:6058-6066
37. Petersen SV, Oury TD, Ostergaard L, et al. Extracellular superoxide dismutase (EC-SOD) binds to type I collagen and protects against oxidative fragmentation. J Biol Chem 2004;279:13705-13710 (Pubitemid 38468899)
38. Nguyen AD, ItohS, Jeney V, et al. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res 2004;95:1067-1074 (Pubitemid 39557893)
39. Juul K, Tybjaerg-Hansen A, Marklund S, et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation 2004;109:59-65. (Pubitemid 38056022)
40. Sandstrom J, Nilsson P, Karlsson K, Marklund SL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparinbinding domain. J Biol Chem 1994;269:19163-19166 (Pubitemid 24226241)
41. Yamada H, Yamada Y, Adachi T, et al. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron 2000;84:218-223 (Pubitemid 30137897)
42. Marklund SL, Nilsson P, Israelsson K, Schampi I, Peltonen M, Asplund K. Two variants of extracellularsuperoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population. J Intern Med 1997;242:5-14. (Pubitemid 27323859)
43. Young RP, Hopkins R, Black PN, et al. Functional variants of antioxidant genes in smokers withCOPD and in those with normal lung function. Thorax 2006;61: 394-399 (Pubitemid 43723321)
44. Kliment CR, Tobolewski JM, Manni ML, Tan RJ, Enghild J, Oury TD. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxid Redox Signal 2008;10:261-268
45. Vreys V, David G. Mammalian heparanase: what is the message? J Cell Mol Med 2007;11:427-452
46. Cao HJ, Fang Y, Zhang X, et al. Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor nB in human gastric carcinoma tissue. World J Gastroenterol 2005;11:903-907 (Pubitemid 40298098)